| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Biology, Pathobiology and Genetics |
Target Gene Carbohydrate Sulfotransferase 10
1Cutaneous Biology Research Center, Massachusetts General Hospital; 2Departments of Otolaryngology and Biochemistry, Cancer Research Center, Boston University School of Medicine, Boston, Massachusetts
* To whom correspondence should be addressed. E-mail: rspan{at}bu.edu.
| Abstract |
|---|
Retinoic acid (RA) induces growth arrest and differentiation of S91 murine melanoma cells and serves as a valuable model for this disease. RA acts through activation of RA receptors (RAR), which are members of the nuclear receptor superfamily of ligand-inducible transcription factors. Interestingly, differentiation is mediated by RAR
, but not by RAR
or RAR
, suggesting that RAR
possesses unique and uncharacterized molecular properties. To address this question, DNA microarrays in combination with RAR isoform-specific agonists were employed to identify novel RAR
target genes that may play a role in this process. Here, we identified and validated carbohydrate sulfotransferase 10 (CHST10) as a novel RAR
target gene in S91 cells. The RAR
-inducible CHST10 promoter was obtained, and two atypical, independently functioning RA response elements were identified in a 425 bp region. Surprisingly, this fragment is bound by RAR
, but not by RAR
or RAR
, thus providing a mechanism for the observed RAR
-specific regulation. CHST10 is a sulfotransferase that forms HNK-1 glycan on neural cell adhesion proteins and glycolipids, and HNK-1 is thought to modulate cell adhesion and possibly metastasis. We show that CHST10 is also regulated by RAR
in a significant subset of human melanoma cells, and three-dimensional cell culture migration assays suggest that CHST10 functions as a suppressor of invasiveness, but not proliferation, in these cells. Induction of CHST10 by RAR
-activating retinoids may present a novel therapeutic strategy to inhibit invasiveness in a subset of melanoma patients. [Canres Res 2009;69(12):OF1–8]
Key Words: promoter, gene expression, S91, HNK-1 ST, differentiation
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |